Showing results (61-70 of 84) with videos related to
Sort By:
Pageof 9
Journal of the American College of Radiology : JACR|August 3, 2025
ACR Neck Imaging Reporting and Data System for MRI Version 2025Paul M Bunch, Ashley H Aiken, Kristen L Baugnon, et al.Journal of Neurointerventional Surgery|October 18, 2011
CT angiography spot sign predicts in-hospital mortality in patients with secondary intracerebral hemorrhageJosser E Delgado Almandoz, Hillary R Kelly, Pamela W Schaefer, et al.JAMA Network Open|December 27, 2024
Radiologist Involvement in Radiation Oncology Peer Review: A Systematic Review and Meta-AnalysisRyan T Hughes, Niema B Razavian, Sydney Smith, et al.JAMA Otolaryngology-- Head & Neck Surgery|June 18, 2026
Pembrolizumab Plus Quad-Shot Radiotherapy for Recurrent, Unresectable, or Metastatic Head and Neck Cancer: A Nonrandomized Clinical TrialRyan T Hughes, Sydney Smith, Thomas W Lycan, et al.Future Oncology (London, England)|May 18, 2023
Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancerRyan T Hughes, Rediet R Gebeyehu, John Mason Kalada, et al.Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 26, 2023
A New (Digital) Era in Medical Journalism: Leveraging Social Media and Other Online Tools to Increase Reach and EngagementKatie S Traylor, Sarah Bastawrous, Erica L Riedesel, et al.Advances in Radiation Oncology|June 5, 2023
Brain Metastasis Incidence and Patterns of Presentation After Definitive Treatment of Locally Advanced Non-Small Cell Lung Cancer: A Potential Argument for Brain Magnetic Resonance Imaging SurveillanceJoshua C Farris, Ryan T Hughes, Niema B Razavian, et al.Therapeutic Advances in Medical Oncology|September 5, 2023
Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literatureChance H Bloomer, Elena Gavrila, Kimberly M Burcher, et al.Therapeutic Advances in Medical Oncology|October 31, 2022
Serendipitous synergism - an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literatureLara M Khoury, Kimberly M Burcher, Ronald T Ng, et al.Cancers|November 27, 2021
Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell CarcinomaKimberly M Burcher, Jeffrey W Lantz, Elena Gavrila, et al.Pageof 9